ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Keywords

Medicine, Task force, Task (project management), Core curriculum, Risk management

References

• Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)Allan J. Lichtman — 1997
• Selecting Target Conditions for Quality of Care Improvement in Vulnerable Older AdultsEskil Ullberg — 2000
• Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.Manel Antolí — 2003
• Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.Charles B. Monroe — 2004
• Review of Studies on the Effect of Bile Acid Sequestrants in Patients with Type 2 Diabetes MellitusPhilip T. Levy — 2010
• Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular diseaseMargarita Camacho Zambrano — 2006
• Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).Antonio Mendoza Fillola, Pedro César Cerrillo Torremocha — 2007
• Cardiovascular and noncardiovascular mortality among patients starting dialysis.Hans-Ludwig Schmidt, Carl Heese, K. Wedlich — 2009
• Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study.Walter. Hallstein — 2009
• Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study.Enrique Gómez-Reino y Carnota — 2011
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38M R Stearne, S L Palmer, M S Hammersley — 1998
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group — 1998
• Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.Carlo Briguori, Gabriella Visconti, Amelia Focaccio — 2009
• Statin adherence and mortality in patients enrolled in a secondary prevention program.Brandy McGinnis, Kari L. Olson, Thomas M A Delate — 2009
• Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.Edward J. Mills, Beth Rachlis, Ping Wu — 2008
• Pleiotropic effects of statins: basic research and clinical perspectivesQian Zhou, James K. Liao — 2010
• Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.室町期諸宗兼学仏教研究会 — 2012
• European cardiovascular disease statisticsSteven Allender, Peter Scarborough, Vito Peto — 2008
• The Epidemiology of Excess Mortality in People with Mental IllnessDavid Lawrence, Stephen Kisely, Joanne Pais — 2010
• Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).Judith Hsia, Jean MacFadyen, John T. Monyak — 2011

Cited by

• Check-up examination: recommendations in adults.Vanessa Virgini, Claudine Meindl-Fridez, Edouard Battegay — 2015
• Dietary intake and adipose tissue level of specific fatty acids in a selected group from the Lower Silesia population.Katarzyna Zatońska, Hannia Campos, Rafał Ilow — 2012
• Estudio de la capacidad fat-binding selectiva de fibras alimentarias y su repercusión sobre el metabolismo lipídicoJonathan Santas Gutiérrez — 2013
• Evaluation of mineral and vitamin intake in the diet of a sample of Polish population - baseline assessment from the prospective cohort 'PONS' study.Rafał Ilow, Bożena Regulska−Ilow, Dorota Różańska — 2011
• Kommentar zu den neuen Leitlinien (2011) der Europäischen Gesellschaft für Kardiologie zum Management von DyslipidämienWolfgang Köenig, Nikolaus Marx, Joachim Thiery — 2012
• Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 studyAntonio Armisén Abós — 2012
• Risk stratification in cardiovascular disease primary prevention – scoring systems, novel markers, and imaging techniquesFaı̈ez Zannad, Guy De Backer, Ian Graham — 2012
• Chronic Kidney Disease, Plasma Lipoproteins, and Coronary Artery Calcium Incidence: The Multi-Ethnic Study of AtherosclerosisAntonio María Martín Rodríguez — 2013
• Gene silencing approaches for the management of dyslipidaemia.April Mandrona — 2013
• Journey Through Cholesteryl Ester Transfer Protein Inhibition: From Bench to BedsideШирина Елена Владимировна — 2013
• Update FettstoffwechselstörungenMaría Concepción Escorial, María Cristina Chueca, Íñigo Loureiro — 2013
• Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: findings from the EUROASPIRE III survey.Е. А. Малышева, А. Н. Цыганов, К. В. Бабешко — 2013
• Second-line treatments for dyslipidemia in patients at risk of cardiovascular disease.David Warlick — 2014
• Cholesterol control according to the presence of metabolic syndrome in coronary and diabetic patients. Relationship with non-alcoholic fatty liver disease.Leila K. Parmee — 2014
• The use of the non-fasting lipid profile for lipid-lowering therapy in clinical practice - point of view.Hardi Warsono — 2014
• Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analoguesNiel Kenneth F. Jamandre — 2015
• [Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines].Miguel Rodrigues — 2015
• Combining detection of Notch1 and tumor necrosis factor-α converting enzyme is a reliable biomarker for the diagnosis of abdominal aortic aneurysms.Рябова Евгения Васильевна — 2015
• The effect of a low-fat spread with added plant sterols on vascular function markers: results of the Investigating Vascular Function Effects of Plant Sterols (INVEST) studyFlorencio J. del Pozo Vindel, José Emilio Herrero Beneítez — 2015
• Comparison of non-HDL-cholesterol versus triglycerides-to-HDL-cholesterol ratio in relation to cardiometabolic risk factors and preclinical organ damage in overweight/obese children: the CARITALY study.Procolo Di Bonito, Giuliana Valerio, Graziano Grugni — 2015

Related papers

• The Design of Curriculum Structure in the Synthesis of School CurriculumDing Nian-jin — 2008
• The Teachers' Curriculum Identity: An Issue Needs Further StudyHuang Xiao-lian — 2011
• Ethnic Minority Elderly: A Task Force Report of the American Psychiatric AssociationEwald W. Busse — 1995
• Postgraduates' Curriculum-selecting Intention and System ReformGuo De-xia — 2009
• Committee and Task Force News: Task Force on Students-at-RiskFlorence W. Kaslow, David L. Olson — 1991
• Change and Review on Core Curriculum for General Education of Fudan UniversityLin Rong-ri — 2012
• The Curriculum Reform of Preschool Education in Higher Vocational CollegesLi Li — 2007